TI-0093 / Therorna - LARVOL DELTA

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Therorna | Enrolling by invitation ➔ Recruiting

Enrollment status • Cervical Cancer • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors (clinicaltrials.gov) - P1 | N=12 | Enrolling by invitation | Sponsor: Therorna | Not yet recruiting ➔ Enrolling by invitation

Enrollment open • Cervical Cancer • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Therorna

New P1 trial • Cervical Cancer • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck